Differential diagnosis of solitary pulmonary nodules based on 99mTc-EDDA/HYNIC-TOC scintigraphy: The effect of tumour size on the optimal method of image assessment

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 9, 2006, Pages 1041-1047

  Płachcińska, Anna ^a   Mikołajczak, Renata ^b   Kozak, Józef ^c   Rzeszutek, Katarzyna ^d   Kuśmierek, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b SOLTAN INSTITUTE FOR NUCLEAR STUDIES   (Poland)

^c N Copernicus Hospital   (Poland)

^d Ctr for Treatm of Pulmon Diseases   (Poland)

Author keywords

Lung cancer; Quantitative; Receptor scintigraphy; Solitary pulmonary nodule; Somatostatin analogue

Indexed keywords

ACETOACETIC ACID DERIVATIVE; ETHYLENEDIAMINE N,N' DIACETIC ACID HYDRAZINONICOTINAMIDE OCTREOTIDE[3 TYROSINE] TC 99M; HYDRAZINE DERIVATIVE; NICOTINAMIDE; OCTREOTIDE[3 TYROSINE]; SOMATOSTATIN DERIVATIVE; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BENIGN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FALSE NEGATIVE RESULT; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; LEIOMYOSARCOMA; LUNG CARCINOMA; LUNG NODULE; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR SCINTISCANNING; TUMOR VOLUME;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 33745881663     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0117-3     Document Type: Article

References (26)

1. Ost D, Fein AM, Feinsilver SH. The solitary pulmonary nodule. N Engl J Med 2003;348:2535-42
2. Hanley KS, Rubin JB. Classifying solitary pulmonary nodules. New imaging methods to distinguish malignant, benign lesions. Postgrad Med 2003;114(2):29
3. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta analysis. JAMA 2001;285:914-24
4. Gambhir SS, Shepherd JE, Shah BD, Hart E, Hah CK, Valk PE, et al. Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol 1998;16(6):2113-25
5. Dietlein M, Weber K, Afschin G, Moka D, Theissen P, Lauterbach KW, et al. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany. Eur J Nucl Med 2000;27:1441-56
6. Bedford M, Maisey MN. Requirements for clinical PET: comparison within Europe. Eur J Nucl Med Mol Imaging 2004;31:208-21
7. 99mTc depreotide in the evaluation of solitary pulmonary nodules. Chest 2000;117:1232-8
8. 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer. Chest 2004;125:494-501
9. Sreedharan SP, Kodama KT, Peterson KE. Distinct subsets of somatostatin receptors in cultured human lymphocytes. J Biol Chem 1989;264:949-53
10. 99mTc-EDDA/HYNIC TOC scintigraphy in differential diagnosis of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 2004;31:1005-10
11. Sortini A, Carcoforo P, Simona A, Sortini D, Pozza E. Significance of a single pulmonary nodule in patients with previous history of malignancy. Eur J Cardiothorac Surg 2001;20:1101
12. Kernstine KH, Kahn D, Menda Y. A new technique for staging potentially resectable lung cancer: NeoTec SPECT Tc-99m (NeoTec) compared with F-18 FDG. American Society of Clinical Program/Proceedings 2001;20:339a
13. Zucker RJ, Bradley YC. Is semi-quantitative NeoTect® scintigraphy the new gold standard for solitary pulmonary nodules? J Nucl Med 2002;228(suppl II):564
14. 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules. Nucl Med Review Cent East Eur 2006; to be published
15. 99mTc-P829. Cancer Res 1998;58:1850-9
16. Freeman LM, Blaufox MD. Letter from the editors. Semin Nucl Med 2002;32(2):77
17. Goldsmith SJ. Guest editorial. Semin Nucl Med 2002;32(2):78
18. 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a pilot study. Cancer Biother Radiopharm 2004;19(2);261-70
19. Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt JS, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin tracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000;27:273-82
20. 99mTc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pumonary nodules. Nucl Med Review Cent East Eur 2004;7(2):143-50
21. 99mTc-EDDA/HYNIC- TOC scintigraphy in differentiation of solitary puomonary nodules - a complementary role to visual analysis. Cancer Biother Radiopharm 2006;21(1):61-7
22. Vesselle H, Schmidt RA, Pugsley JM, Li M, Kohlmyer SG, Vallires E, et al. Lung cancer proliferation correlates with [F-18]fluordeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000;6(10):3837-44
23. Dimitrakopoulou-Strauss A, Georgoulias V, Herth F, Koukouraki S, Maecke H, Haberkorn U, et al. Quantitative assessment of SSTR 2 expression in patients with non-small-cell-lung-cancer using Ga-68-DOTATOC PET and comparison to F-18-FDG. Eur J Nucl Med Mol Imaging 2006; to be published
24. Reubi JC, Krenning E, Lamberts SW, Kvols L. In vitro detection of somatostatin receptors in human tumors. Metabolism 1992;41(9 suppl2):104-10
25. Kwekkeboom DJ, Krenning EP. Somatostatin receptor imaging. Semin Nucl Med 2002;32(2):84-91
26. Reubi JC, Horisberger U, Laissue J. High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction? Int J Cancer 1994;56(5):681-8